Sunepitron

From Wikipedia, the free encyclopedia

Other namesCP-93,393
ATC code
  • none
Sunepitron
Clinical data
Other namesCP-93,393
Routes of
administration
Oral
ATC code
  • none
Identifiers
  • 1-{[2-(pyrimidin-2-yl)octahydro-2H-pyrido[1,2-a]pyrazin-7-yl]methyl}pyrrolidine-2,5-dione
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
Chemical and physical data
FormulaC17H23N5O2
Molar mass329.404 g·mol−1
3D model (JSmol)
  • O=C1N(C(=O)CC1)CC4CCC3N(CCN(c2ncccn2)C3)C4

Sunepitron (developmental code name CP-93,393) is a combined 5-HT1A receptor agonist and α2-adrenergic receptor antagonist.[1][2] It was previously under development by Pfizer for the treatment of depression and anxiety.[3] It made it to phase III clinical trials before being discontinued.[2][3]

Synthesis

See also

References

Related Articles

Wikiwand AI